| Sirolimus for Nosebleeds in HHT (NCT05269849) | Unity Health Toronto | 2022-03-16 |
| Ultra-low-dose Chest CT for HHT (NCT04874558) | Mayo Clinic | 2021-04-21 |
| Bevacizumab In Hereditary Hemorrhagic Telangiectasia (NCT04404881) | Hanny Al-Samkari, MD | 2020-11-23 |
| Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT) (NCT04646356) | Unity Health Toronto | 2020-10-20 |
| Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia (NCT04469517) | University Hospital, Essen | 2020-08-10 |
| Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients (NCT04113187) | University Hospital, Bordeaux | 2020-06-23 |
| Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era. (NCT05752253) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-05-05 |
| Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NCT04139018) | Washington University School of Medicine | 2019-10-20 |
| Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease. (NCT03695874) | Hospices Civils de Lyon | 2019-01-28 |
| CHORUS - Comprehensive HHT Outcomes Registry of the United States (Formerly OUR HHT Registry) (NCT04150822) | Unity Health Toronto | 2018-11-01 |
| Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT) (NCT03691142) | Hospices Civils de Lyon | 2018-10-02 |
| Nationwide Awareness Campaign and Call for Dental Screening for HHT in Germany (NCT03549949) | University Hospital, Essen | 2018-06-01 |
| Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT (NCT02963129) | Hospital Italiano de Buenos Aires | 2017-06-01 |
| MRA With Feraheme in HHT (NCT02977637) | University of California, Los Angeles | 2016-11-01 |
| Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber (NCT02874326) | Radboud University Medical Center | 2016-10-01 |
| Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction (NCT02458703) | Imperial College London | 2015-05-01 |
| Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study (NCT02287558) | The Cleveland Clinic | 2015-01-27 |
| Intranasal Bevacizumab for HHT-Related Epistaxis (NCT02389959) | Stanford University | 2014-08-04 |
| Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NCT02106520) | Hospices Civils de Lyon | 2014-04-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept (NCT01752049) | Unity Health Toronto | 2013-05-01 |
| Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia (NCT01485224) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2011-11-01 |
| Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs (NCT02436213) | Imperial College London | 2011-04-01 |
| Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia (NCT01408732) | University of Minnesota | 2011-02-01 |
| Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (NCT01158807) | Unity Health Toronto | 2010-04-08 |
| Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding (NCT00389935) | Northport Veterans Affairs Medical Center | 2006-10-01 |
| Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial (NCT00375622) | Rabin Medical Center | 2005-02-01 |
| Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (NCT01031992) | University Hospital, Saarland | 2002-03-01 |
| Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia (NCT00004654) | National Center for Research Resources (NCRR) | 1996-01-01 |
| Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients (NCT00004649) | National Center for Research Resources (NCRR) | 1995-05-01 |
| Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia (NCT00004327) | National Center for Research Resources (NCRR) | 1995-01-01 |